DexCom Aktie
WKN: A0D9T1 / ISIN: US2521311074
22.11.2022 15:00:00
|
Dexcom Announces Upcoming Conference Presentation
DexCom, Inc. (NASDAQ:DXCM) today announced that Matt Dolan, Executive Vice President, Strategy, Corporate Development and DexCom Labs, will present an update on the company at the Piper Sandler 34th Annual Healthcare Conference on Wednesday, November 30, 2022 at 8:30am (EST).
Links to the webcast will be available on the Dexcom Investor Relations website at investors.dexcom.com and will be archived there for future reference.
About DexCom, Inc.
DexCom, Inc. empowers people to take real-time control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, and with operations across Europe and select parts of Asia/Oceania, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world. For more information about Dexcom CGM, visit www.dexcom.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221122005202/en/

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu DexCom Inc.mehr Nachrichten
02.05.25 |
Gewinne in New York: Schlussendlich Pluszeichen im NASDAQ 100 (finanzen.at) | |
02.05.25 |
Freundlicher Handel in New York: NASDAQ Composite zum Handelsende mit Zuschlägen (finanzen.at) | |
02.05.25 |
Freundlicher Handel in New York: S&P 500 liegt letztendlich im Plus (finanzen.at) | |
02.05.25 |
Gute Stimmung in New York: So steht der NASDAQ Composite am Nachmittag (finanzen.at) | |
02.05.25 |
Gewinne in New York: Das macht der S&P 500 am Nachmittag (finanzen.at) | |
02.05.25 |
Pluszeichen in New York: NASDAQ 100 klettert nachmittags (finanzen.at) | |
02.05.25 |
Handel in New York: S&P 500 notiert am Mittag im Plus (finanzen.at) | |
02.05.25 |
Börse New York: NASDAQ 100 bewegt sich im Plus (finanzen.at) |
Analysen zu DexCom Inc.mehr Analysen
Aktien in diesem Artikel
DexCom Inc. | 64,14 | 2,71% |
|